WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TENX

Based on 4 analysts offering 12 month price targets for Tenax Therapeutics Inc

Min Forecast
$27.00+120.41%
Avg Forecast
$38.00+210.2%
Max Forecast
$50.00+308.16%

Should I buy or sell TENX stock?

Based on 4 analysts offering ratings for Tenax Therapeutics Inc.

Strong Buy
Strong Buy
4 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TENX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TENX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their TENX stock forecasts and price targets.

TENX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-22Find Out Why
lockedlocked$00.00+00.00%2026-06-22
lockedlocked$00.00+00.00%2026-06-12Find Out Why
lockedlocked$00.00+00.00%2026-03-17

1 of 1

Forecast return on equity

Is TENX forecast to generate an efficient return?

Company
-19.25%
Industry
93.31%
Market
176.08%
TENX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TENX forecast to generate an efficient return on assets?

Company
-17.92%
Industry
27.35%
TENX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TENX earnings per share forecast

What is TENX's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$1.54
Avg 2 year Forecast
-$1.48
Avg 3 year Forecast
-$0.87

TENX revenue forecast

What is TENX's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$38.1M

TENX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TENX$12.25$38.00+210.20%Strong Buy
CNXU$12.18$20.00+64.20%Buy
ABEO$5.75$20.00+247.83%Buy
PALI$1.84$10.50+470.65%Strong Buy
FENC$9.53$15.67+64.40%Strong Buy
View Top Biotech Stocks

Tenax Therapeutics Stock Forecast FAQ

Is Tenax Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: TENX) stock is to Strong Buy TENX stock.

Out of 4 analysts, 4 (100%) are recommending TENX as a Strong Buy, 0 (0%) are recommending TENX as a Buy, 0 (0%) are recommending TENX as a Hold, 0 (0%) are recommending TENX as a Sell, and 0 (0%) are recommending TENX as a Strong Sell.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.

What is TENX's earnings growth forecast for 2026-2028?

(NASDAQ: TENX) Tenax Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.

Tenax Therapeutics's earnings in 2026 is -$57,907,000.On average, 8 Wall Street analysts forecast TENX's earnings for 2026 to be -$40,787,737, with the lowest TENX earnings forecast at -$41,331,503, and the highest TENX earnings forecast at -$38,156,441. On average, 8 Wall Street analysts forecast TENX's earnings for 2027 to be -$39,164,397, with the lowest TENX earnings forecast at -$40,551,663, and the highest TENX earnings forecast at -$36,485,356.

In 2028, TENX is forecast to generate -$22,997,313 in earnings, with the lowest earnings forecast at -$47,570,220 and the highest earnings forecast at $43,448,210.

What is TENX's revenue growth forecast for 2026-2028?

(NASDAQ: TENX) Tenax Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.99%.

Tenax Therapeutics's revenue in 2026 is $0.On average, 8 Wall Street analysts forecast TENX's revenue for 2026 to be $0, with the lowest TENX revenue forecast at $0, and the highest TENX revenue forecast at $0. On average, 8 Wall Street analysts forecast TENX's revenue for 2027 to be $0, with the lowest TENX revenue forecast at $0, and the highest TENX revenue forecast at $0.

In 2028, TENX is forecast to generate $1,010,237,206 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $5,199,726,919.

What is TENX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TENX) forecast ROA is -17.92%, which is lower than the forecast US Biotechnology industry average of 27.35%.

What is TENX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year TENX price target, the average TENX price target is $38.00, with the highest TENX stock price forecast at $50.00 and the lowest TENX stock price forecast at $27.00.

On average, Wall Street analysts predict that Tenax Therapeutics's share price could reach $38.00 by Jun 22, 2027. The average Tenax Therapeutics stock price prediction forecasts a potential upside of 210.2% from the current TENX share price of $12.25.

What is TENX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TENX) Tenax Therapeutics's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that TENX's EPS will be -$1.54 for 2026, with the lowest EPS forecast at -$1.56, and the highest EPS forecast at -$1.44. On average, analysts forecast that TENX's EPS will be -$1.48 for 2027, with the lowest EPS forecast at -$1.53, and the highest EPS forecast at -$1.38. In 2028, TENX's EPS is forecast to hit -$0.87 (min: -$1.79, max: $1.64).

What is TENX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TENX) forecast ROE is -19.25%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.